Combined Hormonal Contraceptives (CHC) Market Global Analysis & 2019 Forecasts adds "Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19)" report to its research store.

Most popular Combined Hormonal Contraceptive products are Nuvaring and Ortho Evra. CHC products are broadly used throughout the world by women in the age-group of 15 to 49 years. With increasing health consciousness and awareness, adoption of CHC products or birth control methods is increasing in lesser privileged economic segments too. The growth of CHC market is driven by urbanization and increasing user awareness, rise in menstruating population globally and initiatives taken by governments to encourage the use of contraception. Major trends prevailing in the market are the increasing number of mergers and acquisitions in this business space and demand for reversible method of contraception with fewer side effects.

Country Coverage: United states, United Kingdom, India, China & Japan

Company Coverage: Agile Therapeutics Inc., Actavis Plc., Bayer Healthcare & Teva Pharmaceuticals

Complete report available at

Combined Hormonal Contraceptives (CHC) is widely being used as an effective and reversible birth control method. Mainly used for preventing pregnancies but sometimes also used for treating acne vulgaris, endometriosis, polycystic ovarian syndrome and irregular menstrual flow, CHC works by preventing ovulation i.e. release of egg from ovaries. The hormones are provided in the combined pill, patch or ring.

The report titled “Global Combined Hormonal Contraceptive (CHC) Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of the global CHC market with detailed analysis of market sizing and growth, market share and economic impact of the industry. The report also assesses key opportunities in the market and outlines the factors that are and will be driving growth of the industry. Growth of the overall CHC industry has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. An insight into strategic issues affecting key brands on the market is provided followed by an analysis of the leading companies in the hormonal contraceptives market. The report also analyzes the key CHC products in pipeline. Further, key players of the industry like Agile Therapeutics; Bayer Healthcare; Teva Pharmaceuticals and Actavis PLC; are analyzed in the report.

Purchase a copy of this report at

Major points from Table of Contents are listed below:

1. Executive Summary   

2. Combined Hormonal Contraceptives Market: An Overview   

3. Combined Hormonal Contraceptives (CHC) Market Analysis   

4. Combined Hormonal Contraceptives (CHC): Market Share Analysis   

5. Combined Hormonal Contraceptives (CHC): Country Analysis   

6. Market Dynamics: Combined Hormonal Contraceptives (CHC) Market   

7. Competitive Landscape: Combined Hormonal Contraceptives (CHC) Market

8. Company Profiles: Combined Hormonal Contraceptives (CHC) Market   

List of Tables and Figures


Explore more reports Pharmaceuticals Market at


About Us:

MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.



Ritesh Tiwari

Corporate Office

TX, Dallas North - Dominion Plaza,

17304, Preston Road,

Suite 800, Dallas 75252.

Tel: + 1 888 391 5441